Suppression of extracellular signal-regulated kinase activity in herpes simplex virus 1-infected cells by the Us3 protein kinase

Journal of Virology

Volumn 86, Issue 15, 2012, Pages 7771-7776

  Chuluunbaatar, Uyanga ^a   Roller, Richard ^b   Mohr, Ian ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE; UNCLASSIFIED DRUG; US3 PROTEIN KINASE;

ALPHAHERPESVIRINAE; ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ANIMALS; CERCOPITHECUS AETHIOPS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, VIRAL; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PROTEIN-SERINE-THREONINE KINASES; VERO CELLS; VIRAL PROTEINS;

HUMAN HERPESVIRUS 1;

EID: 84864389180     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00622-12     Document Type: Article

References (58)

1. Aiamkitsumrit B, et al. 2007. Herpes simplex virus type 1 ICP4 deletion mutant virus d120 infection failed to induce apoptosis in nerve growth factor-differentiated PC12 cells. J. Neurovirol. 13:305-314.
2. Benetti L, Roizman B. 2004. Herpes simplex virus protein kinase US3 activates and functionally overlaps protein kinase A to block apoptosis. Proc. Natl. Acad. Sci. U.S.A. 101:9411-9416.
3. Berra E, Diaz-Meco MT, Moscat J. 1998. The activation of p38 and apoptosis by the inhibition of ERK is antagonized by the phosphoinositide 3-kinase/Akt pathway. J. Biol. Chem. 273:10792-10797.
4. Carracedo A, et al. 2008. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J. Clin. Invest. 118:3065-3074.
5. Carracedo A, Pandolfi PP. 2008. The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene 27:5527-5541.
6. Chuluunbaatar U, Mohr I. 2011. A herpesvirus kinase that masquerades as Akt: you don't have to look like Akt to act like it. Cell Cycle 10:2064-2068.
7. Chuluunbaatar U, et al. 2010. Constitutive mTORC1 activation by a herpesvirus Akt surrogate stimulates mRNA translation and viral replication. Genes Dev. 24:2627-2639.
8. DeLuca N, McCarthy AM, Schaffer P. 1985. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J. Virol. 56:558-570.
9. DeLuca N, Schaffer P. 1988. Physical and functional domains of the herpes simplex virus. J. Virol. 62:732-743.
10. Erazo A, Yee MB, Banfield BW, Kinchington PR. 2011. The alphaherpesvirus US3/ORF66 protein kinases direct phosphorylation of the nuclear matrix protein matrin 3. J. Virol. 85:568-581.
11. Feldman ME, et al. 2009. Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol. 7:e38. doi: 10.1371/journal.pbio.1000038.
12. Gillis PA, Okagaki LH, Rice SA. 2009. Herpes simplex virus 1 ICP27 induces p38 mitogen-activated protein kinase signaling and apoptosis in HeLa cells. J. Virol. 83:1767-1777.
13. Goldstein DJ, Weller SK. 1988. Herpes simplex virus type-1 ribonucleotide reductase activity is dispensable for virus growth andDNAsynthesis: isolation and characterization of an ICP6 lacZ insertion mutant. J. Virol. 62:196-205.
14. Hargett D, McLean T, Bachenheimer SL. 2005. Herpes simplex virus ICP27 activation of stress kinases JNK and p38. J. Virol. 79:8348-8360.
15. Howe AK, Juliano RL. 2000. Regulation of anchorage-dependent signal transduction by protein kinase A and p21-activated kinase. Nat. Cell Biol. 2:593-600.
16. Hu J, et al. 2001. ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-beta-dependent gene transcription in response to interferongamma. J. Biol. Chem. 276:287-297.
17. Izumi KM. 2004. Epstein-Barr virus signal transduction and B-lymphocyte growth transformation. Prog. Mol. Subcell. Biol. 36:269-288.
18. Kang MH, Banfield BW. 2010. Pseudorabies virus tegument protein Us2 recruits the mitogen-activated protein kinase extracellular-regulated kinase (ERK) to membranes through interaction with the ERK common docking domain. J. Virol. 84:8398-8408.
19. Kato A, et al. 2005. Identification of proteins phosphorylated directly by the Us3 protein kinase encoded by herpes simplex virus 1. J. Virol. 79: 9325-9331.
20. Kolch W. 2005. Coordinating ERK/MAPK signaling through scaffolds and inhibitors. Nat. Rev. Mol. Cell Biol. 6:827-837.
21. Lassus P, et al. 2000. Extinction of Rac1 and Cdc42Hs signaling defines a novel p53 dependent apoptotic pathway. Oncogene 19:2377-2385.
22. Leach N, et al. 2007. Emerin is hyperphosphorylated and redistributed in herpes simplex virus type 1-infected cells in a manner dependent on both UL34 and Us3. J. Virol. 81:10792-10803.
23. Leader DP, Deana AD, Marchiori F, Purves FC, Pinna LA. 1991. Further definition of the substrate specificity of the α-herpesvirus protein kinase and comparison with protein kinases A and C. Biochim. Biophys. Acta 1091:426-431.
24. Liang L, Roizman B. 2008. Expression of gamma interferon-dependent genes is blocked independently by virion host shutoff RNase and by the Us3 protein kinase. J. Virol. 82:4688-4696.
25. Liu X, Li Q, Dowdell K, Fischer ER, Cohen JL. 2012. Varicella-zoster virus ORF12 protein triggers phosphorylation of ERK1/2 and inhibits apoptosis. J. Virol. 86:3143-3151.
26. Long MC, Leong V, Schaffer PA, Spencer CA, Rice SA. 1999. ICP22 and the UL13 protein kinase are both required for herpes simplex virusinduced modification of the large subunit of RNA polymerase II. J. Virol. 73:5593-5604.
27. McKay MM, Morrison DK. 2007. Integrating signals from RTKs to ERK/MAPK. Oncogene 26:3113-3121.
28. McLean TI, Bachenheimer SL. 1999. Activation of cJun N-terminal kinase by herpes simplex virus type 1 enhances viral replication. J. Virol. 73:8415-8426.
29. Meindl A, Osterrieder N. 1999. The equine herpesvirus 1 Us2 homolog encodes a non-essential membrane associated virion component. J. Virol. 73:3430-3437.
30. Mendoza MC, Emrah Er E, Blenis J. 2011. The Ras-ERK and PI3KmTOR pathways: cross-talk and compensation. Trends Biochem. Sci. 36: 320-328.
31. Moria I, et al. 2003. The US3 protein kinase of herpes simplex virus attenuates the activation of the c-Jun N-terminal protein kinase signal transduction pathway in infected piriform cortex neurons of C57BL/6 mice. Neurosci. Lett. 351:201-205.
32. Moria I, et al. 2006. Herpes simplex virus Us3 protein kinase regulates virus-induced apoptosis in olfactory and vomeronasal chemo-sensory neurons in vivo. Microbes Infect. 8:1806-1812.
33. Mou F, Forest T, Baines JD. 2007. Us3 of herpes simplex virus type 1 encodes a promiscuous protein kinase that phosphorylates and alters localization of lamin A/C in infected cells. J. Virol. 81:6459-6470.
34. Munger J, Roizman B. 2001. The US3 protein kinase of herpes simplex virus 1 mediates the posttranslational modification of BAD and prevents BAD-induced programmed cell death in the absence of other viral proteins. Proc. Natl. Acad. Sci. U.S.A. 98:10410-10415.
35. Murphy LO, Blenis J. 2006. MAPK signal specificity: the right place at the right time. Trends Biochem. Sci. 31:268-275.
36. Ogg PD, McDonell PJ, Ryckman BJ, Knudson CM, Roller RJ. 2004. The HSV-1 Us3 protein kinase is sufficient to block apoptosis induced by overexpression of a variety of Bcl-2 family members. Virology 319:212-224.
37. Overton H, McMillan D, Hope L, Wong-Kai-In P. 1994. Production of host shutoff-defective mutants of herpes simplex virus type 1 by inactivation of the UL13 gene. Virology 202:97-106.
38. Perkins D, Pereira EF, Aurelian L. 2003. The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) functions as a dominant regulator of apoptosis in hippocampal neurons involving activation of the ERK survival pathway and upregulation of the antiapoptotic protein Bag-1. J. Virol. 77:1292-1305.
39. Pleschka S. 2008. RNA viruses and the mitogenic Raf/MEK/ERK signal transduction cascade. Biol. Chem. 389:1273-1282.
40. Preston VG, Palfreyman JW, Dutia BM. 1984. Identification of a herpes simplex virus type 1 polypeptide which is a component of the virusinduced ribonucleotide reductase. J. Gen. Virol. 65:1457-1466.
41. Rajaiya J, Xiao J, Rajala RV, Chodosh J. 2008. Human adenovirus type 19 infection of corneal cells induces p38 MAPK-dependent interleukin-8 expression. Virol. J. 5:17.
42. Rommel C, et al. 1999. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286:1738-1741.
43. Roy SK, Wachira SJ, Weihua X, Hu J, Kalvakolanu DV. 2000. CCAAT/enhancer-binding protein-beta regulates interferon-induced transcription through a novel element. J. Biol. Chem. 275:12626-12632.
44. Rozengurt E. 2007. Mitogenic signaling pathways induced by G proteincoupled receptors. J. Cell. Physiol. 213:589-602.
45. Ryckman BJ, Roller RJ. 2004. Herpes simplex virus type 1 primary envelopment: UL34 protein modification and the US3-UL34 catalytic relationship. J. Virol. 78:399-412.
46. Sacks WR, Schaffer PA. 1987. Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture. J. Virol. 61:829-839.
47. γ1134.5 mutants of herpes simplex virus 1. J. Virol. 80:1110-1120.
48. Van den Broekea C, et al. 2009. Alphaherpesvirus Us3-mediated reorganization of the actin cytoskeleton is mediated by group A p21-activated kinases. Proc. Natl. Acad. Sci. U.S.A. 106:8707-8712.
49. Wagner EK, Nebreda AR. 2009. Signal integration by JNK and p38 MAPKpathways in cancer and development. Nat. Rev. Cancer 9:537-540.
50. Walsh D, et al. 2008. Eukaryotic translation initiation factor 4F architectural alterations accompany translation initiation factor redistribution in poxvirus-infected cells. Mol. Cell. Biol. 28:2648-2658.
51. Walsh D, Mohr I. 2004. Phosphorylation of eIF4E by Mnk1 enhances HSV-1 translation and replication in quiescent cells. Genes Dev. 18:660-672.
52. Walsh D, Perez C, Notary J, Mohr I. 2005. Regulation of the translation initiation factor eIF4F by multiple mechanisms in human cytomegalovirus-infected cells. J. Virol. 79:8057-8064.
53. Walters MS, Kinchington PR, Banfield BW, Silverstein SJ. 2010. Hyperphosphorylation of histone deacetylase 2 by alphaherpesvirus US3 kinases. J. Virol. 84:9666-9676.
54. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
55. Yu F, et al. 2007. Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus. PLoS Pathog. 3(3):e44. doi: 10.1371/journal.ppat.0030044.
56. Yu JH, Lin BY, Deng W, Broker TR, Chow LT. 2007. Mitogen-activated protein kinases activate the nuclear localization sequence of human papillomavirus type 11 E1 DNA helicase to promote efficient nuclear import. J. Virol. 81:5066-5078.
57. Zachos G, Clements B, Conner J. 1999. Herpes simplex virus type 1 infection stimulates p38/c-Jun N-terminal mitogen-activated protein kinase pathways and activates transcription factor AP-1. J. Biol. Chem. 274: 5097-5103.
58. Zugasti O, et al. 2001. Raf-MEK-Erk cascade in Anoikis is controlled by Rac1 and Cdc42 via Akt. Mol. Cell. Biol. 21:6706-6717.